Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
27 March 2018 Photo Earl Coetzee
Research focus on HIV and TB stigma among healthcare workers
Posters reading, “Let’s Stop Stigma” urge healthcare workers to ”Be kind to yourself. Be kind to others.” Pictured here are Dr Asta Rau, Director of CHSR&D and Dr Michelle Engelbrecht, deputy director of the centre.

Researchers working on an internationally funded project are tackling a key occupational health issue: HIV and TB stigma among Free State healthcare workers. They developed and rolled out interventions to decrease stigma and will soon measure the effects. 
In this four-year project, UFS researchers from the Centre for Health Systems Research and Development (CHSR&D) are partnering with Antwerp University and the Free State Department of Health.  

Stigma is like an invisible mark 
A project leader at the CHSR&D, Dr Asta Rau, says most research on stigma in public health focuses on HIV stigma towards patients. Little is done on stigma among healthcare workers themselves. 
Dr Rau says that stigma undermines people’s dignity and causes them suffering. It can even stop them from seeking healthcare. Stigma threatens the health of healthcare workers and the stability of the health system, which is already under strain due to personnel shortages. 

Interventions to make a difference

The research identified two types of stigma - external stigma that can be seen around us, e.g. in the way healthcare workers speak about or treat one another and internal stigma that happens when healthcare workers take this ‘outside’ stigma and turn it inward on themselves. 

Dr Rau says the interventions involve training healthcare workers about what stigma is and how to go about reducing it. “We give them the knowledge and tips on how to communicate when they encounter stigma. It is up to them to then use that to fight stigma.” A communication campaign with posters and branded social marketing materials supports the training. The campaign uses a single slogan: ”Let’s Stop Stigma” and urges healthcare workers to ”Be kind to yourself. Be kind to others."

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept